Justin Scheer
34Patents
4h-index
50Co-inventors
62Inventor score
Filing activity: Apr 16, 2009 → Mar 4, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9637557B2 | Production of heteromultimeric proteins | Emerging Cross-Sectional Technologies | 52 | Active |
| US9815880B2 | IL-22 Fc fusion proteins | Chemistry; Metallurgy | 11 | Active |
| US10160793B2 | Methods of treating inflammatory bowel disease using IL-22 Fc fusion proteins | Chemistry; Metallurgy | 5 | Active |
| US10626189B2 | Assembly of bispecific antibodies | Chemistry; Metallurgy | 5 | Active |
| US9862778B2 | Assembly of bispecific antibodies | Chemistry; Metallurgy | 4 | Active |
| US8563839B2 | Methods of reducing leaf senescence using methyl dihydrojasmonate | Human Necessities | 4 | Active |
| US10407510B2 | Anti-factor D antibodies and conjugates | Chemistry; Metallurgy | 4 | Active |
| US10087227B2 | Nucleic acids encoding IL-22 Fc fusion proteins | Chemistry; Metallurgy | 3 | Active |
| US8013226B2 | Methods for reducing leaf senescence using methyl dihydrojasmonate | Human Necessities | 2 | Active |
| US10941190B2 | Production of heteromultimeric proteins using mammalian cells | Chemistry; Metallurgy | 1 | Active |
| US9301524B2 | Methods for reducing leaf senescence using methyl dihydrojasmonate | Human Necessities | 1 | Active |
| US10584181B2 | Methods of making and using multispecific antibody panels and antibody analog panels | Chemistry; Metallurgy | 1 | Active |
| US11332541B2 | Multi-specific binding proteins for cancer treatment | Chemistry; Metallurgy | 1 | Active |
| US11725065B2 | Assembly of bispecific antibodies | Chemistry; Metallurgy | 0 | Active |
| US11732045B2 | Multi-specific binding proteins for cancer treatment | Chemistry; Metallurgy | 0 | Active |
| US10179821B2 | Anti-factor D antibodies | Chemistry; Metallurgy | 0 | Active |
| US11130791B2 | Methods for treating metabolic syndrome using IL-22 Fc fusion proteins | Chemistry; Metallurgy | 0 | Active |
| US12146000B2 | Bispecific and tetravalent CD137 and FAP molecules for the treatment of cancer | Chemistry; Metallurgy | 0 | Active |
| US12173083B2 | Multi-specific binding proteins for cancer treatment | Chemistry; Metallurgy | 0 | Active |
| US11332507B2 | IL-22 Fc fusion proteins | Chemistry; Metallurgy | 0 | Active |
| US10689447B2 | Fc variants and methods for their production | Chemistry; Metallurgy | 0 | Active |
| US10654932B2 | Anti-factor D antibody variant conjugates and uses thereof | Chemistry; Metallurgy | 0 | Active |
| US12030947B2 | Humanized and affinity matured antibodies to FcRH5 and methods of use | Physics | 0 | Active |
| US11912773B2 | Fc variants and methods for their production | Chemistry; Metallurgy | 0 | Active |
| US12030926B2 | Production of heteromultimeric proteins using mammalian cells | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.